NCT00550303View on ClinicalTrials.gov

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

bazedoxifene/conjugated estrogens combination

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00550303 - Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens | Biotech Hunter | Biotech Hunter